As a first approach to establish whether the deleterious effects of recombinant oTau on LTP and memory occur with authentic AD tau species, we obtained preparations enriched in soluble tau from human AD brain specimens (AD-Tau) and control specimens from age-matched individuals (HC). Here, MAPT is linked to Alzheimer disease.